{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:40:28Z","timestamp":1787240428028,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.mcna.2023.05.017","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T08:11:59Z","timestamp":1689063119000},"page":"93-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acquired Demyelinating Syndromes"],"prefix":"10.1016","volume":"108","author":[{"given":"Dominic O.","family":"Co","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mcna.2023.05.017_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11940-019-0603-0","article-title":"Acute Transverse and Flaccid Myelitis in Children","volume":"21","author":"Theroux","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2023.05.017_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","article-title":"Incidence of acquired demyelination of the CNS in Canadian children","volume":"72","author":"Banwell","year":"2009","journal-title":"Neurology"},{"issue":"9 Supplement 2","key":"10.1016\/j.mcna.2023.05.017_bib3","first-page":"S46","article-title":"Pediatric transverse myelitis","volume":"87","author":"Absoud","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mcna.2023.05.017_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1542\/pir.2019-0179","article-title":"Acute Transverse Myelitis and Acute Disseminated Encephalomyelitis","volume":"41","author":"Kahn","year":"2020","journal-title":"Pediatr Rev"},{"issue":"11","key":"10.1016\/j.mcna.2023.05.017_bib5","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/0883073812452916","article-title":"Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis","volume":"27","author":"Wolf","year":"2012","journal-title":"J\u00a0Child Neurol"},{"issue":"6","key":"10.1016\/j.mcna.2023.05.017_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol Zurich Switz"},{"issue":"11","key":"10.1016\/j.mcna.2023.05.017_bib7","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1212\/WNL.0000000000201662","article-title":"Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter Study","volume":"100","author":"Carta","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mcna.2023.05.017_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"issue":"9 Supplement 2","key":"10.1016\/j.mcna.2023.05.017_bib9","first-page":"S53","article-title":"Pediatric optic neuritis","volume":"87","author":"Yeh","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mcna.2023.05.017_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaapos.2011.05.020","article-title":"Pediatric optic neuritis and risk of multiple sclerosis: meta-analysis of observational studies","volume":"15","author":"Waldman","year":"2011","journal-title":"J\u00a0AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.mcna.2023.05.017_bib11","first-page":"4281772","article-title":"Characteristics of Optic Neuritis in South Korean Children and Adolescents: A Retrospective Multicenter Study","volume":"2022","author":"Park","year":"2022","journal-title":"J\u00a0Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2023.05.017_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40272-021-00441-7","article-title":"Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient","volume":"23","author":"Wang","year":"2021","journal-title":"Paediatr Drugs"},{"issue":"11","key":"10.1016\/j.mcna.2023.05.017_bib13","first-page":"210","article-title":"Acute Disseminated Encephalomyelitis: Current Perspectives","volume":"7","author":"Paolilo","year":"2020","journal-title":"Child Basel Switz"},{"issue":"10","key":"10.1016\/j.mcna.2023.05.017_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.autrev.2015.06.002","article-title":"A\u00a0spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children","volume":"14","author":"Esposito","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"16 Supplement","key":"10.1016\/j.mcna.2023.05.017_bib15","doi-asserted-by":"crossref","first-page":"P5139","DOI":"10.1212\/WNL.86.16_supplement.P5.139","article-title":"Acute Disseminated Encephalomyelitis. A Fourteen Years Review (P5.139)","volume":"86","author":"Monllor","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.mcna.2023.05.017_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler J"},{"issue":"2","key":"10.1016\/j.mcna.2023.05.017_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9 Supplement 2","key":"10.1016\/j.mcna.2023.05.017_bib18","first-page":"S59","article-title":"Neuromyelitis optica spectrum disorders in children and adolescents","volume":"87","author":"Tenembaum","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2023.05.017_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fped.2020.00339","article-title":"Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis","volume":"8","author":"Tenembaum","year":"2020","journal-title":"Front Pediatr"},{"issue":"9 Supplement 2","key":"10.1016\/j.mcna.2023.05.017_bib20","first-page":"S103","article-title":"Pediatric multiple sclerosis: Escalation and emerging treatments","volume":"87","author":"Chitnis","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2023.05.017_bib21","doi-asserted-by":"crossref","first-page":"103531","DOI":"10.1016\/j.msard.2022.103531","article-title":"Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective study","volume":"59","author":"Martins","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.mcna.2023.05.017_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jns.2018.02.028","article-title":"A\u00a0comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment","volume":"388","author":"Baghbanian","year":"2018","journal-title":"J\u00a0Neurol Sci"},{"issue":"3","key":"10.1016\/j.mcna.2023.05.017_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mcna.2023.05.017_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc"},{"issue":"8","key":"10.1016\/j.mcna.2023.05.017_bib25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2015-311743","article-title":"Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease","volume":"87","author":"Lechner","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.mcna.2023.05.017_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2023.05.017_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neurol.2019.02.002","article-title":"Pediatric onset multiple sclerosis","volume":"176","author":"Deiva","year":"2020","journal-title":"Rev Neurol (Paris)"},{"issue":"8","key":"10.1016\/j.mcna.2023.05.017_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archneurol.2009.135","article-title":"Difference in Disease Burden and Activity in Pediatric Patients on Brain Magnetic Resonance Imaging at Time of Multiple Sclerosis Onset vs Adults","volume":"66","author":"Waubant","year":"2009","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2023.05.017_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40263-021-00887-w","article-title":"Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment","volume":"36","author":"Jakimovski","year":"2022","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.mcna.2023.05.017_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2023.05.017_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2352-4642(18)30026-9","article-title":"MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study","volume":"2","author":"Fadda","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"10.1016\/j.mcna.2023.05.017_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","article-title":"Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment","volume":"22","author":"Bennett","year":"2023","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2023.05.017_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1542\/peds.2006-0655","article-title":"on behalf of the KIDSEP Study Group. Prognostic Factors for Early Severity in a Childhood Multiple Sclerosis Cohort","volume":"118","author":"Mikaeloff","year":"2006","journal-title":"Pediatrics"},{"issue":"13","key":"10.1016\/j.mcna.2023.05.017_bib34","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1177\/1352458518786655","article-title":"T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes","volume":"24","author":"Wong","year":"2018","journal-title":"Mult Scler J"},{"issue":"11","key":"10.1016\/j.mcna.2023.05.017_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1212\/WNL.0000000000206805","article-title":"Should We test for IgG Antibodies Against MOG in Both Serum and CSF in Patients With Suspected MOGAD?","volume":"100","author":"Kim","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2023.05.017_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejpn.2020.11.001","article-title":"U.\u00a0paediatric MOG consortium. E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Armangue","year":"2020","journal-title":"Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc"},{"issue":"10","key":"10.1016\/j.mcna.2023.05.017_bib37","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.1212\/WNL.0000000000008057","article-title":"Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes","volume":"93","author":"Wong","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mcna.2023.05.017_bib38","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1177\/1352458518775303","article-title":"High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome","volume":"25","author":"van der Vuurst de Vries","year":"2019","journal-title":"Mult Scler J"},{"issue":"9","key":"10.1016\/j.mcna.2023.05.017_bib39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2018-317969","article-title":"CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications","volume":"89","author":"Kaneko","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.mcna.2023.05.017_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(20)30432-4","article-title":"Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care","volume":"20","author":"Fadda","year":"2021","journal-title":"Lancet Neurol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523000779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523000779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:49:46Z","timestamp":1758419386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712523000779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0025712523000779"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2023.05.017","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired Demyelinating Syndromes","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2023.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}